COMMUNIQUÉS West-GlobeNewswire

Motif Bio Confirms Receipt of Deficiency Notice from Nasdaq
26/07/2019
NEW YORK, July 26, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/Nasdaq: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that it has received a deficiency [...]
ObsEva SA Reports Positive Feedback from Independent Data Monitoring Committee for PROLONG Part B with OBE022
26/07/2019
Geneva, Switzerland and Boston, MA – July 26, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Janssen reports positive top-line Phase 3 results for ponesimod in adults with relapsing multiple sclerosis
26/07/2019
Data are part of the OPTIMUM study comparing the efficacy and safety of ponesimod and Aubagio ® in adults with relapsing multiple sclerosis Idorsia Pharmaceuticals Ltd, J&J and Actelion Pharmaceuticals Ltd have a [...]
Geocann Appoints Medical and Scientific Advisory Board to Expand Its Leadership Position in Research and Innovation
26/07/2019
The prestigious group is comprised of a multidisciplinary collective with decades of well-documented and published work as well as prominent careers focused on advancing the therapeutic benefits of science-backed [...]
MediPharm Labs Announces Trading Date on the Toronto Stock Exchange
25/07/2019
TORONTO, July 25, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, [...]
Aptevo Therapeutics Reports Continued Progress In APVO210 and APVO436 Clinical Trials
25/07/2019
Completes Dosing in Single Ascending Dose (SAD) Phase 1 Study of APVO210 Receives Approval to Begin APVO210 Multiple Ascending Dose (MAD) Study Preliminary Data Suggest that Single Doses of APVO210 Appear to be Safe and [...]
Neuronetics to Present at the 39th Annual Canaccord Genuity Growth Conference
25/07/2019
MALVERN, Pa., July 25, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for [...]
Natus Medical Announces Second Quarter 2019 Financial Results
25/07/2019
Second quarter revenue of $125.5 million exceeded expectations Second quarter GAAP earnings per share of $0.12 Second quarter non-GAAP earnings per share of $0.34 exceeded expectations NASDAQ ticker symbol change to “ [...]
Shineco, Inc. to Launch Hemp Based Cosmeceutical Products in August
25/07/2019
BEIJING, July 25, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and [...]
Stryker reports second quarter 2019 operating results
25/07/2019
Kalamazoo, Michigan, July 25, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2019: Second Quarter Highlights Reported net sales increased 9.9% to $3.7 billion Organic [...]
Otonomy to Report Second Quarter 2019 Financial Results and Provide Corporate Update
25/07/2019
Webcast and Conference Call to be Held at 4:30 p.m. EDT on August 1, 2019 SAN DIEGO, July 25, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative [...]
Inspire Medical Systems, Inc. Announces Changes to its Board of Directors
25/07/2019
Gary L. Ellis, Former Medtronic Chief Financial Officer, Joins Company’s Board MINNEAPOLIS, July 25, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (the “Company” or “Inspire”), a medical technology [...]
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
25/07/2019
MENLO PARK, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on August 1, 2019. [...]
TransMedics to Present at the 39th Annual Canaccord Genuity Global Growth Conference
25/07/2019
ANDOVER, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, [...]
GenMark Diagnostics to Participate in the Canaccord Genuity Growth Conference
25/07/2019
CARLSBAD, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to [...]
Strong clinical progress in H1 and transformative collaboration with Gilead announced
25/07/2019
First half-year financial results: Group revenues of €108.5 million Operating loss of €97.6 million Net loss of €95.9 million Cash and cash equivalents on 30 June 2019 of €1,148 million Further development of our broad [...]
Merit Medical Reports Earnings For Second Quarter of 2019
25/07/2019
Q2 2019 worldwide revenue of $255.5 million, up 13.7% as reported over Q2 2018 Q2 2019 core revenue on a comparable, constant currency basis* up 9.6% over Q2 2018 Q2 2019 GAAP EPS was $0.12, compared to $0.21 in Q2 2018 [...]
Adverum Biotechnologies to Host a Conference Call and Webcast to Report Second Quarter 2019 Financial Results and Provide Corporate Updates
25/07/2019
MENLO PARK, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular diseases, today announced that it will [...]
Cytokinetics to Announce Second Quarter Results on August 8, 2019
25/07/2019
SOUTH SAN FRANCISCO, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that it is scheduled to report second quarter results on August 8, 2019 at 4:00 PM Eastern Time. [...]

Pages